Human infectious fungal diseases are increasing, despite improved hygienic conditions. We present a case of gastrointestinal basidiobolomycosis (GIB) in a 20-year-old male with a history of progressively worsening abdominal pain. The causative agent was identified as a novel species. Validation of its novelty was established by analysis of the partial ribosomal operon of two isolates from different organs. Phylogeny of ITS and LSU rRNA showed that these isolates belonged to the genus positioned closely to and . Morphological and physiological data supported the identity of the species, which was named , with CBS 146281 as the holotype. The strains showed high minimum inhibitory concentrations (MICs) to fluconazole (>64 µg/mL), itraconazole and voriconazole (>16 µg/mL), anidulafungin and micafungin (>16 µg/mL), but had a low MIC to amphotericin B (1 µg/mL). The pathogenic role of in gastrointestinal disease is discussed. We highlight the crucial role of molecular identification of these rarely encountered opportunistic fungi.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400364PMC
http://dx.doi.org/10.3390/jof7080653DOI Listing

Publication Analysis

Top Keywords

>16 µg/ml
8
nov causing
4
causing angioinvasive
4
angioinvasive abdominal
4
abdominal basidiobolomycosis
4
basidiobolomycosis human
4
human infectious
4
infectious fungal
4
fungal diseases
4
diseases increasing
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!